These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21273787)

  • 81. Potential Mechanisms of Age Acceleration Caused by Estrogen Deprivation: Do Endocrine Therapies Carry the Same Risks?
    Sehl ME; Ganz PA
    JNCI Cancer Spectr; 2018 Jul; 2(3):pky035. PubMed ID: 31360862
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Activation of GPER ameliorates experimental pulmonary hypertension in male rats.
    Alencar AK; Montes GC; Montagnoli T; Silva AM; Martinez ST; Fraga AG; Wang H; Groban L; Sudo RT; Zapata-Sudo G
    Eur J Pharm Sci; 2017 Jan; 97():208-217. PubMed ID: 27836751
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Heart Disease in Women: Unappreciated Challenges, GPER as a New Target.
    Feldman RD
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213340
    [TBL] [Abstract][Full Text] [Related]  

  • 84. 17β-Estradiol and Agonism of G-protein-Coupled Estrogen Receptor Enhance Hippocampal Memory via Different Cell-Signaling Mechanisms.
    Kim J; Szinte JS; Boulware MI; Frick KM
    J Neurosci; 2016 Mar; 36(11):3309-21. PubMed ID: 26985039
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.
    Menazza S; Murphy E
    Circ Res; 2016 Mar; 118(6):994-1007. PubMed ID: 26838792
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Activation of GPR30 inhibits cardiac fibroblast proliferation.
    Wang H; Zhao Z; Lin M; Groban L
    Mol Cell Biochem; 2015 Jul; 405(1-2):135-48. PubMed ID: 25893735
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tumor protein D52-like 2 contributes to proliferation of breast cancer cells.
    Yang M; Wang X; Jia J; Gao H; Chen P; Sha X; Wu S
    Cancer Biother Radiopharm; 2015 Feb; 30(1):1-7. PubMed ID: 25629696
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Activation of G protein coupled estrogen receptor (GPER) promotes the migration of renal cell carcinoma via the PI3K/AKT/MMP-9 signals.
    Guan BZ; Yan RL; Huang JW; Li FL; Zhong YX; Chen Y; Liu FN; Hu B; Huang SB; Yin LH
    Cell Adh Migr; 2018 Mar; 12(2):109-117. PubMed ID: 25588050
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo.
    Wei W; Chen ZJ; Zhang KS; Yang XL; Wu YM; Chen XH; Huang HB; Liu HL; Cai SH; Du J; Wang HS
    Cell Death Dis; 2014 Oct; 5(10):e1428. PubMed ID: 25275589
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Expression of the oestrogen receptor GPER by testicular peritubular cells is linked to sexual maturation and male fertility.
    Sandner F; Welter H; Schwarzer JU; Köhn FM; Urbanski HF; Mayerhofer A
    Andrology; 2014 Sep; 2(5):695-701. PubMed ID: 25052196
    [TBL] [Abstract][Full Text] [Related]  

  • 91. G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease.
    Han G; White RE
    World J Cardiol; 2014 Jun; 6(6):367-75. PubMed ID: 24976908
    [TBL] [Abstract][Full Text] [Related]  

  • 92. GPER functions as a tumor suppressor in triple-negative breast cancer cells.
    Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A
    J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Estrogen biology: new insights into GPER function and clinical opportunities.
    Prossnitz ER; Barton M
    Mol Cell Endocrinol; 2014 May; 389(1-2):71-83. PubMed ID: 24530924
    [TBL] [Abstract][Full Text] [Related]  

  • 94. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.
    Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910
    [TBL] [Abstract][Full Text] [Related]  

  • 95. DNA microarray-based gene expression profiling of estrogenic chemicals.
    Kiyama R; Zhu Y
    Cell Mol Life Sci; 2014 Jun; 71(11):2065-82. PubMed ID: 24399289
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Whole chromosome gain does not in itself confer cancer-like chromosomal instability.
    Valind A; Jin Y; Baldetorp B; Gisselsson D
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21119-23. PubMed ID: 24324169
    [TBL] [Abstract][Full Text] [Related]  

  • 97. GPER-1 acts as a tumor suppressor in ovarian cancer.
    Ignatov T; Modl S; Thulig M; Weißenborn C; Treeck O; Ortmann O; Zenclussen A; Costa SD; Kalinski T; Ignatov A
    J Ovarian Res; 2013 Jul; 6(1):51. PubMed ID: 23849542
    [TBL] [Abstract][Full Text] [Related]  

  • 98. G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation.
    Chakrabarti S; Davidge ST
    PLoS One; 2012; 7(12):e52357. PubMed ID: 23285008
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner.
    Holm A; Grände PO; Ludueña RF; Olde B; Prasad V; Leeb-Lundberg LM; Nilsson BO
    Mol Cell Biochem; 2012 Jul; 366(1-2):239-49. PubMed ID: 22451019
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer.
    Kolkova Z; Casslén V; Henic E; Ahmadi S; Ehinger A; Jirström K; Casslén B
    J Ovarian Res; 2012 Mar; 5():9. PubMed ID: 22424333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.